Nearly one in five babies in Brazil born ‘small’ and at risk of early childhood death
18% of babies born in Brazil over seven years were born ‘small’ – either preterm,
one
Plant-based milks: which one is healthier for you and the planet?
The milk aisle of the supermarket is a very different place to what it was
Austria in talks to buy one million Sputnik V doses
Austria said on Tuesday it was negotiating with Russia over the possible purchase of one
There IS one medicine that definitely comes with a risk of blood clots
There IS one medicine that definitely comes with a risk of blood clots – and
Have a Case of a Covid Variant? No One Is Going to Tell You
Covid-19 infections from variant strains are quickly spreading across the U.S., but there’s one big
Video: COVID, one year later: What do we know now?
At the start of the COVID-19 pandemic, we switched up our usual content to bring
Once bitten, twice shy: Researchers explore the neurology of why one bad curry could put us off for life
A negative experience with food usually leaves us unable to stomach the thought of eating
COVID-19 survivors may only need one vaccine dose, study suggests
COVID-19 survivors may only need one vaccine dose because they already have high levels of
'Health' tonic with your ENTIRE daily sugar limit in one dose
‘Health’ tonic with your ENTIRE daily sugar limit in one dose: We review a selection
Karyopharm Announces FDA Approval of Xpovio (selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
NEWTON, Mass., Dec. 18, 2020 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial stage